Search

Author/Creator Wu, Jianwrong

1. Initial testing (stage 1) of M6620 (formerly VX‐970), a novel ATR inhibitor, alone and combined with cisplatin and melphalan, by the Pediatric Preclinical Testing Program. Issue 2 (17th September 2017)

Authors:
Kurmasheva, Raushan T.; Kurmashev, Dias; Reynolds, C. Patrick; Kang, Min; Wu, Jianwrong; Houghton, Peter J.; Smith, Malcolm A.
Journal:
Pediatric blood & cancer
Issue:
Volume 65:Issue 2(2018)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Initial Testing (Stage 1) of MK‐8242—A Novel MDM2 Inhibitor—by the Pediatric Preclinical Testing Program. Issue 10 (30th May 2016)

Authors:
Kang, Min H.; Reynolds, C. Patrick; Kolb, E. Anders; Gorlick, Richard; Carol, Hernan; Lock, Richard; Keir, Stephen T.; Maris, John M.; Wu, Jianwrong; Lyalin, Dmitry; Kurmasheva, Raushan T.; Houghton, Peter J.; Smith, Malcolm A.
Journal:
Pediatric blood & cancer
Issue:
Volume 63:Issue 10(2016)
Page Start:
1744
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Initial testing (stage 1) of tazemetostat (EPZ‐6438), a novel EZH2 inhibitor, by the Pediatric Preclinical Testing Program. Issue 3 (24th August 2016)

Authors:
Kurmasheva, Raushan T.; Sammons, Melissa; Favours, Edward; Wu, Jianwrong; Kurmashev, Dias; Cosmopoulos, Katherine; Keilhack, Heike; Klaus, Christine R.; Houghton, Peter J.; Smith, Malcolm A.
Journal:
Pediatric blood & cancer
Issue:
Volume 64:Issue 3(2017)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search